AML92 protocol
chemotherapy protocol consisting of enocitabine, all-trans retinoic acid, and daunorubicin; used against acute promyelocytic leukemia
Networked: 1
relevant articles (0 outcomes,
1 trials/studies)
Therapy Context: Research Results
Related Diseases
Related Drugs and Biologics
Related Therapies and Procedures